6 Results for "

Theranostic Agent

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Theranostic Agent" in MCE Product Catalog:

Cat. No.: HY-75706
CAS No.: 763111-47-3
Research Areas:  

Cancer

N-Descyclopropanecarbaldehyde Olaparib is an analogue of Olaparib (HY-10162) containing DOTA moiety. N-Descyclopropanecarbaldehyde Olaparib is a PARP inhibitor used for synthesizing novel dual EGFR and PARP PROTAC, DP-C-4 (HY-141481) . N-Descyclopropanecarbaldehyde Olaparib can be radiolabeled with F-18 or fluorophore for positron emission tomography (PET) or optical imaging in several types of tumor .
loading...
    loading...
Cat. No.: HY-121462
CAS No.: 523-42-2
Purity:  ≥98.0%
Synonyms: Quinoline Blue
Cyanine is an excellent fluorescent core scaffold for constructing fluorescent probes. Covalent conjugation of Cyanine with other potent compounds can not only enhance their efficacy but also expand their application modes. Cyanine supports the development of cancer theranostic agents. Cyanine can be used in cancer research .
loading...
    loading...
Cat. No.: HY-155485
Research Areas:  

Cancer

Abi-DZ-1 is a potential multifunctional theranostic agent via the HIF1α/OATPs pathway. Abi-DZ-1 can be used in the research of tumor-targeted imaging and precision therapy .
loading...
    loading...
Cat. No.: HY-163077
Research Areas:  

Cancer

Anticancer agent 175 (complex 1) ia a near-infrared (NIR) luminescent theranostic complex. Anticancer agent 175 induces ROS accumulation, mitochondrial damage, disruption of Bax/Bcl-2 equilibrium, and tumor cell apoptosis in HepG2 cell line .
loading...
    loading...
Cat. No.: HY-P10648
CAS No.: 3027722-28-4
Synonyms: HER2-targeting peptide
Target:  

EGFR

Research Areas:  

Cancer

Herceptide (HER2-targeting peptide) is a HER2-targeting peptide, and can be further conjugated to the near-infrared fluorescent dye indocyanine green (HY-D0711) (ICG) for developing theranostic agents .
loading...
    loading...
Cat. No.: HY-155070
Research Areas:  

Cancer

SRE-II, an amide derivative, is an activatable photosensitizer for photodynamic cancer research with decreased fluorescence and photosensitizing capabilities. SRE-II can be further converted into the active photosensitizer SDU Red via carboxylesterase-catalyzed amide bond cleavage. SRE-II induces DNA damage and cell apoptosis in the presence of light. SRE-II can act as a promising theranostic agent for triple-negative breast cancer .
loading...
    loading...